000045903 000__ 00852cam\a22003735i\4500
000045903 001__ 45903
000045903 003__ SzGeWIPO
000045903 005__ 20240708150219.0
000045903 006__ m\\\\eo\\d\\\\\\\\
000045903 007__ cr bn |||m|||a
000045903 008__ 220425s2022\\\\enk\\\\\o\\\\\000\0\eng\d
000045903 035__ $$a(OCoLC)1335039256
000045903 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000045903 041__ $$aeng
000045903 24500 $$aBasic and Improvement Patents in COVID-19 Vaccines.
000045903 264_1 $$a[Oxford, England] :$$bOxford University Press (OUP),$$c2022
000045903 300__ $$a1 online resource (pages 393-394)
000045903 336__ $$atext$$2rdacontent
000045903 337__ $$acomputer$$2rdamedia
000045903 338__ $$aonline resource$$bcr$$2rdacarrier
000045903 4901_ $$aGRUR International,$$x2632-8550 ;$$v71, 5, 2022
000045903 542__ $$fhttps://academic.oup.com/grurint/article/71/5/393/6549214
000045903 588__ $$aCrossref
000045903 590__ $$aPublished online: 16-Mar-22
000045903 650_4 $$aCovid-19.
000045903 650_4 $$aPatent Law.
000045903 650_0 $$aPatents.
000045903 7001_ $$aMusso, Alberto,$$eauthor.
000045903 7731_ $$tGRUR International$$wGRUR
000045903 830_0 $$aGRUR International ;$$v71, 5, 2022.
000045903 85641 $$uhttps://academic.oup.com/grurint/article/71/5/393/6549214$$yonline version
000045903 904__ $$aJournal article
000045903 980__ $$aGRUR